Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. (Q40798689)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. |
scientific article |
Statements
1 reference
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. (English)
1 reference
M Cuello
1 reference
S A Ettenberg
1 reference
A S Clark
1 reference
M M Keane
1 reference
R H Posner
1 reference
M M Nau
1 reference
P A Dennis
1 reference
S Lipkowitz
1 reference
1 June 2001
1 reference
1 reference
4892-4900
1 reference